Norway's King Harald V Hospitalized for Treatment Complications
Translated from Spanish, summarized and contextualized by DistantNews.
At a glance
- King Harald V of Norway, 89, was hospitalized due to complications from treatment for hemolytic anemia.
- He will be on medical leave for two weeks, during which Crown Prince Haakon will assume regency.
- The King has faced several health issues in recent years but has repeatedly dismissed calls to abdicate.
Norway's King Harald V, Europe's oldest monarch at 89, has been hospitalized due to complications arising from his treatment for hemolytic anemia. The Royal House announced that the King will be on medical leave for two weeks, during which his son, Crown Prince Haakon, will act as regent and perform constitutional duties.
King Harald has been undergoing cortisone treatment for hemolytic anemia, a condition causing the rapid destruction of red blood cells, leading to symptoms like fatigue and paleness. The medication resulted in fluid retention, necessitating hospital care. While the Royal House did not report further complications, the duration of his hospital stay remains unspecified.
This latest hospitalization adds to a series of recent health episodes for the King, who has occupied the throne since 1991. Despite progressively reduced official duties due to various health problems, Harald has consistently rejected the idea of abdicating, reaffirming his commitment to serve for life.
Recent medical issues include hospitalization in February for infection and dehydration during a private trip to Spain, as well as previous infections and cardiac procedures, including the implantation of a permanent pacemaker in 2024. His son, Crown Prince Haakon, will again step in to manage constitutional tasks, a role he has undertaken during previous periods of the King's illness. The health of the royal family has also been impacted by Crown Princess Mette-Marit's chronic lung disease.
Originally published by La Naciรณn in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.